Missing Data and Censoring in the Analysis of Progression-Free Survival in Oncology Clinical Trials

Author： Denne J. S.   Stone A. M.   Bailey-Iacona R.   Chen T.-T.  

Publisher： Taylor & Francis Ltd

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.23, Iss.5, 2013-09, pp. : 951-970

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relationship between response rates and median progression‐free survival in non‐Hodgkin's lymphoma: A meta‐analysis of published clinical trials

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 37-43

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluating and Adjusting for Premature Censoring of Progression-Free Survival

By Rothmann Mark   Koti Kallappa   Lee Kyung Yul   Lu Hong Laura   Shen Yuan Li   Zhang Jenny J.   Jin Mei   Zhou Haojin  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 1091-1105

Taylor & Francis Ltd

Access to resources Recommend Favorite

Intermediate clinical endpoints: A bridge between progression-free survival and overall survival in ovarian cancer trials

By Matulonis Ursula A.   Oza Amit M.   Ho Tony W.   Ledermann Jonathan A.  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1737-1746

Blackwell Publishing

Access to resources Recommend Favorite

Evaluation of Discordance Measures in Oncology Studies with Blinded Independent Central Review of Progression-Free Survival Using an Observational Error Model

By Mannino F. V.   Amit O.   Lahiri S.  

Journal of Biopharmaceutical Statistics, Vol. 23, Iss. 5, 2013-09 ,pp. : 971-985

Taylor & Francis Ltd

Access to resources Recommend Favorite

Missing Data in Confirmatory Clinical Trials

By Flyer Paul   Hirman Joseph  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 6, 2009-11 ,pp. : 969-979

Taylor & Francis Ltd

Access to resources Recommend Favorite